---
figid: PMC3701226__fimmu-04-00178-g002
figtitle: Signaling pathways triggered by TCR and CD28 engagement
organisms:
- Mus musculus
- Rattus norvegicus
- Bos taurus
- Canis lupus familiaris
- Homo sapiens
- Caenorhabditis elegans
- Coxsackievirus
- NA
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Bos taurus
- Canis lupus familiaris
- Drosophila melanogaster
pmcid: PMC3701226
filename: fimmu-04-00178-g002.jpg
figlink: /pmc/articles/PMC3701226/figure/F2/
number: F2
caption: Signaling pathways triggered by TCR and CD28 engagement. When the TCR engages
  a cognate peptide-MHC complex in the presence of appropriate co-stimulatory signals,
  this activates TCR proximal tyrosine kinases (PTKs) and results in the recruitment
  of a number of adaptor molecules. Eventually, the activation of PLCγ1 enables it
  to hydrolyze membrane PIP2 to form second messengers IP3 and DAG. IP3 activates
  the calcineurin-NFAT pathway, while DAG activates the Ras-ERK-AP1 and NF-κB pathways.
  DGKs dampen DAG-mediated signals by converting DAG to PA. CD28 engagement plays
  an important role in the activation of PKCθ and the PI3K-Akt-mTOR axis. Recent work
  (indicated by thick arrows) has shown that TCR signaling can also directly activate
  mTOR complexes via the Ras-ERK pathway, and that such activation is negatively regulated
  by DGK activity. ERK can also activate Mnk1/2 kinases that phosphorylate eIF4E to
  promote translation. PA is produced in T cells by the action of both DGKs and PLDs
  (not shown in this figure). In other cell types, PA has been shown to activate Raf1
  and mTORc1. Please refer to the text for more details about TCR-triggered signaling
  pathways and effector molecules that bind to DAG or PA.
papertitle: Regulation of Lipid Signaling by Diacylglycerol Kinases during T Cell
  Development and Function.
reftext: Sruti Krishna, et al. Front Immunol. 2013;4:178.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.959025
figid_alias: PMC3701226__F2
figtype: Figure
redirect_from: /figures/PMC3701226__F2
ndex: 0b3cd954-dedc-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3701226__fimmu-04-00178-g002.html
  '@type': Dataset
  description: Signaling pathways triggered by TCR and CD28 engagement. When the TCR
    engages a cognate peptide-MHC complex in the presence of appropriate co-stimulatory
    signals, this activates TCR proximal tyrosine kinases (PTKs) and results in the
    recruitment of a number of adaptor molecules. Eventually, the activation of PLCγ1
    enables it to hydrolyze membrane PIP2 to form second messengers IP3 and DAG. IP3
    activates the calcineurin-NFAT pathway, while DAG activates the Ras-ERK-AP1 and
    NF-κB pathways. DGKs dampen DAG-mediated signals by converting DAG to PA. CD28
    engagement plays an important role in the activation of PKCθ and the PI3K-Akt-mTOR
    axis. Recent work (indicated by thick arrows) has shown that TCR signaling can
    also directly activate mTOR complexes via the Ras-ERK pathway, and that such activation
    is negatively regulated by DGK activity. ERK can also activate Mnk1/2 kinases
    that phosphorylate eIF4E to promote translation. PA is produced in T cells by
    the action of both DGKs and PLDs (not shown in this figure). In other cell types,
    PA has been shown to activate Raf1 and mTORc1. Please refer to the text for more
    details about TCR-triggered signaling pathways and effector molecules that bind
    to DAG or PA.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cd28
  - Trav6-3
  - Dguok
  - Dgke
  - Dgkb
  - Dgkh
  - Plcg1
  - Prkcq
  - Rasgrp1
  - Pik3r1
  - Akt1
  - ras
  - Hras
  - Kras
  - Rem1
  - Bcl10
  - Card11
  - Tsc1
  - Malt1
  - Raf1
  - Ear1
  - Mdk
  - Ephb2
  - Mapk1
  - Eif4ebp1
  - Rps6kb1
  - Eif4e
  - Nfkbib
  - Nfkb1
  - Atp7a
  - Jun
  - CD28
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - DGKB
  - DGUOK
  - DGKE
  - DGKA
  - DGKD
  - DGKG
  - DGKH
  - DGKQ
  - DGKZ
  - DGKI
  - DGKK
  - PLCG1
  - RASGRP1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - KRAS
  - HRAS
  - NRAS
  - BCL10
  - CARD11
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - TSC1
  - CCL26
  - MALT1
  - RAF1
  - RNASE3
  - RPTOR
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - EPHB2
  - MAPK1
  - MAPK3
  - EIF4EBP1
  - RPS6KB1
  - EIF4E
  - EIF4E2
  - EIF4E3
  - NFKB1
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - ATP7A
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - Pik3cg
  - Rnase2
  - Ephb1
  - Nfat5
  - LOC505306
  - TARP
  - Tcr
  - Dgk
  - rdgA
  - Gk2
  - CG34384
  - Pa
  - sl
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Ras64B
  - Ras85D
  - Raf
  - ca
  - Crtc
  - Dsor1
  - Mtk
  - IKKepsilon
  - key
  - IKKbeta
  - Erk7
  - rl
  - Thor
  - S6k
  - eIF4E1
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4EHP
  - Dif
  - dl
  - Rel
  - NFAT
  - lok
  - AP-1gamma
  - Jra
  - kay
  - Cancer
---
